Some exciting SAM news: We have three new experts joining our science advisory board! Read more about SAM’s accomplished new advocates below – and register for our August summit in Baltimorefeaturing Drs. Huestis and Weiner here.
“SAM is thrilled to welcome three new experts who will amplify the influence and reach of our science advisory board,” said SAM President Kevin Sabet. “SAM has always been committed to science and evidence-based marijuana policy, and our new advisors each reflect this health-first approach.”
Dr. Marilyn Huestis is an adjunct professor at University of
 |
 |
|
Dr. Marilyn Huestis |
Ma ryland’s School of Medicine and recently retired from her position as NIDA’s Chief of Chemistry and Drug Metabolism last year after a 23-year career with the Institute. Professor Huestis is a world-renowned expert on human drug testing, publishing 453 manuscripts and book chapters on the topic and serves on five editorial boards. Her research focuses on effects of occasional and frequent cannabinoid use on pregnancy and child outcomes, brain function and driving impairment, and on novel psychoactive substances – synthetic cannabinoids. She received her Ph.D. in toxicology from University of Maryland, Baltimore, and was awarded an honorary doctoral degree in medicine and surgery from University of Helsinki in Finland. Professor Huestis is past president of the Society of Forensic Toxicology, the Toxicology Section of the American Academy of Forensic Sciences, and the International Association of Forensic Toxicologists, and has received numerous national and international awards recognizing her research and contributions to public health and safety.
Dr. Yifrah Kaminer i s a child and adolescent psychiatrist with an appointment as a Professor of Psychiatry at University of Connecticut
|
 |
|
Dr. Yifrah Kaminer |
School of Medicine’s Alcohol Research Center and Professor of Pediatrics at Connecticut Children’s Medical Center’s Injury Prevention Center. Dr. Kaminer’s research focuses on the assessment and treatment of youth substance use disorders. He has authored/edited five books, published more than 160 scientific articles, and guest edited journals including Substance Abuse Journal and American Journal of Addictions. He received his M.D. from Tel-Aviv University in Israel, and his MBA from the University of Hartford. Dr. Kaminer is also coordinator of the Youth Treatment Section of the Research Society on Marijuana (RSMj)’s advisory board.
Dr. Aaron Weiner is a licensed clinical psychologist and director of
|
 |
|
Dr. Aaron Weiner |
a ddiction services at Linden Oaks Behavioral Healthcenter in Illinois, which has been recognized by the independent Joint Commission accreditor with a Gold Seal of Approval for its excellent treatment of drug addiction. Dr. Weiner is a strong advocate for evidence-based care in treating cannabis use disorder, as well as for integrating behavioral health services into medical settings. He earned his Ph.D. in counseling psychology from the University of Illinois at Urbana-Champaign and completed his postdoctoral fellowship in addiction psychology with the VA Ann Arbor Healthcare System in Michigan.